<DOC>
	<DOCNO>NCT01635608</DOCNO>
	<brief_summary>To visualize localization measure volume water small intestine T2-weighted MRI image oral administration 240 ml water ( non-caloric water ) administration 240 ml water contain 25.5 g sucrose ( 105 kcal , caloric water ) . To measure pharmacokinetics probe-drugs paracetamol , talinolol amoxicillin oral administration dissolve 240 ml non-caloric 240 ml caloric water .</brief_summary>
	<brief_title>Absorption Paracetamol , Talinolol Amoxicillin After Oral Administration Using Non-caloric Caloric Water</brief_title>
	<detailed_description>After swallow , drug first deposit stomach together co-swallowed water . However , stomach major place drug absorption . Therefore , kinetics gastric empty play crucial role absorption process . In case dissolve finely suspend drug particle , gastric empty drug occur together gastric content . The emptied liquid enters small intestine absorb . Under fast condition , empty phase consist water co-swallowed drug ( clinical study typically 240 ml ) together small volume gastric juice . Under fed condition , empty liquid phase caloric suspension . It known gastric empty intestinal absorption pure water rapid lead usually rapid absorption water soluble drug take fasting condition . In contrary , delayed absorption postprandial condition typically relate delay gastric emptying . However , velocity extent intestinal filling absorption rate liquid phase gut lumen unknown . Therefore , primary objective study determine gastric empty kinetics 240 ml water ( non-caloric water ) 240 ml water contain 25.5 g sucrose ( 105 kcal , caloric water ) , respective intestinal fill absorption rate intestinal liquid use water sensitive magnetic resonance imaging ( MRI ) . To evaluate functional meaning gastric emptying , intestinal filling water uptake oral drug absorption swallow non-caloric caloric water , pharmacokinetics paracetamol , talinolol amoxicillin study administration 240 ml non-caloric 240 ml caloric water , respectively . Paracetamol ( acetaminophen ) chosen , rapidly completely absorbed part gut . The time appearance blood expect surrogate rate gastric emptying . It hypothesize caloric content water administration influence extent paracetamol absorption . Talinolol represent well establish probe drug intestinal efflux transport protein ABCB1 . Because expression ABCB1 increase along small intestine ( duodenum &lt; jejunum &lt; ileum ) , hypothesize , administration talinolol caloric water lead low bioavailability increase fecal excretion drug . Amoxicillin act probe drug intestinal drug uptake via dipeptide transporter PEPT1 predominately express proximal part small intestine ( ( duodenum &gt; jejunum &gt; ileum ) . Because region-specific expression , hypothesize , administration amoxicillin caloric water associate low bioavailability .</detailed_description>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Talinolol</mesh_term>
	<criteria>age : 18 45 year sex : male female ethnic origin : white body weight 19 27 kg/mÂ² good health evidence result clinical examination , ECG , laboratory checkup , judge clinical investigator differ clinical relevant way normal state write informed consent weight less 45 kg claustrophobia cardiac pacemaker , metallic implant metalcontaining tatoos know allergic reaction active ingredient use constituent study medication bronchial asthma ( stage ) exist cardiac hematological disease and/or pathological finding , might interfere drug 's safety , tolerability and/or pharmacokinetics ( e.g . tachycardia ) hepatic renal disease and/or pathological finding , might interfere pharmacokinetics pharmacodynamics study medication gastrointestinal disease and/or pathological finding , might interfere pharmacokinetics pharmacodynamics study medication drug alcohol dependence positive drug alcohol screen smoker 10 cigarette per day positive result HIV , HBV HCV screening subject diet could affect pharmacokinetics drug heavy tea coffee drinker ( 1L per day ) lactation pregnancy test positive perform subject suspect know follow instruction subject unable understand write verbal instruction , particular regard risk inconvenience expose result participation study subject liable orthostatic dysregulation , fainting , blackouts participation clinical trial last 3 month prior start study le 14 day last acute disease le 3 month last blood donation systemically available medication within 2 week prior intend first administration unless terminal elimination halflife complete elimination body assume drug and/or primary metabolite ( except oral contraceptive ) intake grapefruit poppy seed contain product within 14 day prior administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Talinolol</keyword>
	<keyword>Amoxicillin</keyword>
	<keyword>Acetaminophen</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
</DOC>